Key facts, as of
As of November 2, 2026, Stryker Corporation (SYK) trades at $305.71, down 14.2% over the past year. Its 52-week range runs from $267.00 to $389.33; the price is 21.5% below that high. It is 24.7% below its all-time high of $406.19, reached in January 2025. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +182.6%, against +316.3% for the S&P 500 (SPY). It sits 5.5% below its 200-day average of $323.54. Its 30-day volatility is 39.4% annualized, which we rate high risk. It has a trailing P/E of 32.6 and a dividend yield of 1.21%.
Cite: Portfolio Terminal, "Stryker Corporation (SYK) stock analysis", 2026-11-02. https://portfolio-terminal.com/analyse/syk
Where it trades today
trading 32% of the way up its 52-week range
How the price has moved
How far it is from its record
Stryker Corporation (SYK) is 24.7% below its all-time high of $406.19, reached in January 2025. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +182.6%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- SYK closes above its 50-day average ($292.23) while the 50-day is still under the 200-day ($323.54): a rebound inside a longer decline, not yet an uptrend.
- At $305.71, SYK is 21.5% below its 1-year high of $389.33, set on March 2, 2026, and 14.5% above its 1-year low of $267.00 (September 11, 2026).
- Over the past month SYK rose 11.0%, from $275.43 to $305.71.
- SYK trades at 32.6x its last twelve months of earnings and 18.7x the next twelve months' estimate, so analysts expect earnings 73.8% higher.
- Its P/E is 20.5% below the 40.9x median of the 3 other medical devices companies we track (ABT, BSX, EW).
- SYK's 30-day volatility, 39.4% a year, works out to a typical daily move of about 2.5%.
- Yahoo Finance puts its beta at 0.77: over five years of monthly returns, SYK moved about 0.77% for each 1% move of the S&P 500.
What would change the read
- The rebound holds while it closes above the 50-day average, $292.23 (−4.4%); it becomes an uptrend when the 50-day climbs 10.7% to cross the 200-day at $323.54.
- A close above $389.33 (+27.4%) would be a new 1-year high; below $267.00 (−12.7%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for SYK, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under medical devices among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for SYK by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for SYK. Last refresh: Nov 2, 2026, 7:10 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Medical Devices.
What Stryker Corporation does
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical…
What analysts expect
SYK carries a buy consensus from 27 analysts, with an average price target of $341.37 versus $305.71 today (+11.7%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
SYK generated $26.30B in trailing revenue (7.6% year over year), with a 13.8% net margin, and $3.70B of free cash flow, against $12.16B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $25.12B | $16.07B | $5.06B | $3.25B | $8.49 | $4.28B |
| 2024 | $22.59B | $14.44B | $4.67B | $2.99B | $7.86 | $3.49B |
| 2023 | $20.50B | $13.06B | $3.92B | $3.17B | $8.34 | $3.14B |
| 2022 | $18.45B | $11.58B | $3.11B | $2.36B | $6.23 | $2.04B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
SYK is in 18 of the 54 ETFs we track. It weighs most in XLV: 1.60% of the fund, holding #18 of 62.
Famous investors who hold it
SYK is in the latest 13F of 1 of the 15 famous investors we follow. Terry Smith (Fundsmith) holds the most of it: 6.72% of the portfolio, position #2 of 41, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
SYK beside the other companies Yahoo Finance files under medical devices among the assets we track (ABT, BSX, EW, largest first).
SYKyou are here$305.71$116.38B
ABTAbbott Laboratories$110.11$190.53B
BSXBoston Scientific$44.12$63.94B
EWEdwards Lifesciences$92.44$53.28BWhat the chart is saying
Back above its 50-day average, still under the long-term trend.
recovering- Price is 4.6% above its 50-day average and 5.5% below its 200-day.
- RSI at 57 is neither stretched nor washed out.
- The nearest ceiling is $318.82 (+4.3%), the nearest floor $290.74 (-4.9%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is SYK valued right now?
Stryker Corporation trades at 32.6 times its last twelve months of earnings and 18.7 times the next twelve months' estimate (Yahoo Finance, November 2, 2026). On the chart: back above its 50-day average, still under the long-term trend. Price is 4.6% above its 50-day average and 5.5% below its 200-day.
What is the risk level of SYK?
Based on 30-day volatility of 39.4%, SYK has HIGH risk. Its beta of 0.77 means it has swung less than the S&P 500 over the last five years.
Does SYK pay dividends?
Yes, Stryker Corporation has a dividend yield of 1.21%.
How far is SYK from its all-time high?
Stryker Corporation is 24.7% below its all-time high of $406.19, reached in January 2025. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +182.6%, against +316.3% for the S&P 500 (SPY).
Which ETFs hold SYK?
18 of the 54 popular ETFs we track hold Stryker Corporation. The largest weights: XLV (1.60%), JEPI (0.62%), VIG (0.43%), VTV (0.36%) and RSP (0.21%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is SYK?
0.15%, as of September 30, 2026: SYK is holding #115 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $1.46 in Stryker Corporation.
Which famous investors own SYK?
Terry Smith (6.72% of Fundsmith's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for SYK?
The average analyst price target for Stryker Corporation (SYK) is $341.37 based on 27 analyst estimates, about 11.7% above the current price of $305.71. The published range runs from $275.00 to $465.00.
How much revenue does SYK generate?
Stryker Corporation reported $26.30B in trailing twelve-month revenue. Revenue growth is running at 7.6% year over year. Net margin sits at 13.8%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare SYK with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.